Data de publicação: 22/04/2024 - 16:10
Fiocruz has taken another important step towards strengthening and implementing institutional initiatives and policies in favor of ethnic-racial and gender equity, diversity and inclusion. On Tuesday and Wednesday (April 11th and 12th, 2023), the Foundation launched the Ethnic-Racial and Gender Equity Policy and presented to the internal community the new Coordination of Equity, Diversity, Inclusion and Affirmative Policies (Cedipa), established...
Notícias
Data de publicação: 16/04/2024 - 15:33
The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies of the Oswaldo Cruz Institute (IOC/Fiocruz) is part of a new cooperation network of the World Health Organization (WHO) to monitor the different types of coronavirus. Called CoViNet, the initiative is an offshoot of the network of reference laboratories set up by WHO at the start of the public health emergency caused by Sars-CoV-2. The group brings together...
Notícias
Data de publicação: 16/04/2024 - 15:12
Fiocruz hosted, from April 8th to 12th, the Fiocruz-Pasteur Network International Course on bioproduction, intellectual property and technology transfer. In the auditorium of the Rocha Lima Pavilion, on the Manguinhos Campus in Rio de Janeiro, 11 foreign students and 7 students from different units of the Foundation discussed topics such as research, development, production, quality control, clinical studies, regulatory issues and the...
Notícias
Data de publicação: 16/04/2024 - 14:30
Fiocruz Pernambuco has created a 100% national ingredient to be added to the rapid screening test for the diagnosis of visceral leishmaniasis (VL). The product can be used for both the human and canine populations, being the first with this dual efficacy. The product has already been assessed in laboratories and will soon be implemented in the field. VL is an infectious disease transmitted by the drain fly that can affect both humans and animals...
Notícias
Data de publicação: 12/04/2024 - 11:02
During dengue epidemics, the resulting deaths, with rare exceptions, are avoidable. Dengue does not kill. What kills is the lack of care and attention to the signs of worsening that can appear, especially when the fever disappears. This neglected moment leads to avoidable serious cases and deaths.
Most of the avoidable deaths from dengue are the result of several errors, three of which stand out. The first is when patients or their families...
Notícias
Data de publicação: 11/04/2024 - 11:14
A survey of indigenous Yanomami people, from the Ninam subgroup, from nine villages located in Roraima, showed that all participants were contaminated by mercury. The highest levels of exposure were detected in indigenous people living in the villages closest to the illegal gold mines. The study Impact of Mercury on Protected Areas and Forest Peoples in the Amazon: An Integrated Health-Environment Approach was conducted by the Sergio Arouca...
Notícias
Data de publicação: 11/04/2024 - 10:02
In front of representatives from 24 countries, Fiocruz opened on 4/3, and hosted until 4/5, the Second Global Workshop for countries presenting Voluntary National Reviews (VNRs), part of a series of three meetings organized by the United Nations to draw up proposals to be taken to the UN High-Level Political Forum on Sustainable Development (HLPF) in July. This is the first time the workshop has been held in Latin America, and its opening was...
Notícias
Data de publicação: 03/04/2024 - 16:03
The Institute of Technology on Immunobiologicals (Bio-Manguinhos/Fiocruz) and the pharmaceutical company Sanofi signed a Memorandum of Understanding last Wednesday (3/27) that reaffirms their mutual interest in establishing further collaborations in the field of immunization. In January this year, the institutions signed a technology transfer agreement for the domestic production of the acellular hexavalent vaccine. The immunizer offers...
Notícias
Data de publicação: 03/04/2024 - 14:29
Fiocruz, through the Institute of Drug Technology (Farmanguinhos/Fiocruz) and the René Rachou Institute (IRR/Fiocruz Minas), has signed a partnership agreement for research, development and innovation (RD&I) with the French pharmaceutical company Servier. The aim is to enable research into cancer treatments using natural samples. The event was attended by the presidents of France, Emmanuel Macron, and of Fiocruz, Mario Moreira....
Notícias
Data de publicação: 01/04/2024 - 14:36
Last week, on a trip to China, Fiocruz was able to strengthen partnerships and prospect future cooperation in health technology and innovation, especially in the areas of vaccines, biologicals and advanced therapies. The Foundation's vice president for Health Production and Innovation, Marco Krieger, and the director of the Immunobiological Technology Institute (Bio-Manguinhos), Maurício Zuma, were in the Asian country to visit health...
Notícias
Data de publicação: 27/03/2024 - 14:05
The historic Fiocruz complex in Manguinhos, in Northern Rio de Janeiro, is a candidate for World Heritage status by the United Nations Educational, Scientific and Cultural Organization (UNESCO). The institution is now part of the tentative list of sites that can become Cultural, Natural and Mixed World Heritage Sites, a primary and obligatory stage for any property to begin the process of recognition.
Inscription of the historical complex...
Notícias
Data de publicação: 27/03/2024 - 11:25
With international partners, Fiocruz has launched a research project that aims to contribute to the health of populations and ecosystems in the Amazon and East Africa in the face of climate change and environmental degradation. The aim is to establish information systems to support local communities in border areas in assessing the impacts of environmental transformations on their well-being and in developing actions to prevent, adapt to and...
Notícias
Data de publicação: 26/03/2024 - 15:34
A survey carried out by Fiocruz/Unifase's Observatory of Children's Health (Observa Infância) reveals that dengue fever has hit children up to the age of 5 hardest in 2024. The analysis shows that adolescents between the ages of 10 and 14 have the highest number of cases recorded this year, while children under the age of 5 have the highest fatality rates, followed by those between the ages of 5 and 9. Observa Infância...
Notícias
Data de publicação: 26/03/2024 - 09:20
Fiocruz, a foundation from the Brazilian government's Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic...
Notícias
Data de publicação: 22/03/2024 - 16:38
The constant heat waves caused by climate change, combined with incomplete urbanization and the large circulation of people in certain areas, are influencing the spread of the dengue fever into the hinterlands of the country. This is revealed by the study Climate change, thermal anomalies, and the recent progression of dengue in Brazil, published on Nature's Scientific Reports portal. The text was written by researcher Christovam Barcellos,...
Notícias
Data de publicação: 20/03/2024 - 15:58
In an opinion article – Heat waves, climate crisis and adaptation challenges in the global south metropolises –, published on March 8 in the international open access publisher PLOS, researcher Christovam Barcellos, from Fiocruz, warns of the challenges faced in adapting the global south metropolises to climate change, especially heat waves, pointing out that, in these areas, issues such as the supply of drinking water, electricity...
Notícias
Data de publicação: 20/03/2024 - 15:20
Fiocruz has taken another step forward on the road to cooperation with Malaysia. Visiting the country two weeks ago for the Dengue Alliance meeting, the Foundation's Vice President of Production and Innovation in Health, Marco Krieger, took part in various activities in which he discussed possibilities for cooperation, the Health Industrial Complex, the mRNA vaccine and innovation in health. During the trip, it was planned to sign a...
Notícias
Data de publicação: 20/03/2024 - 10:56
Leonardo Bastos, a researcher at the Scientific Computation Program of Fiocruz (PROCC/Fiocruz), won the "Study UK Alumni Awards 2024" on February 28th from the British Council organisation in Brasília. According to the British Council's Director of Cultural Engagement, Diana Daste, "in 2024, the tenth edition of the Study UK Alumni Awards received a total of 1,450 entries from alumni from nearly 100 countries." In...
Notícias
Data de publicação: 14/03/2024 - 09:43
Jack A. Tuszynski, professor at the University of Alberta in Canada and the Polytechnic Institute of Turin, in Italy, will give an online research seminar on computational modeling applied to health on March 20, at 2 pm (Brasília time). Entitled Measuring and modeling electro conductive and quantum properties of cytoskeletal protein filaments exposed to electromagnetic fields, the seminar will bring a physics perspective to intracellular...
Notícias
Data de publicação: 12/03/2024 - 11:53
The president of Fiocruz, Mario Moreira, and the Spanish ambassador to Brazil, Mar Fernández-Palacios Carmona, signed, last Wednesday (3/6), a memorandum of understanding between the Foundation and the Carlos III Health Institute. The agreement was signed in the presence of president Luiz Inácio Lula da Silva and minister Nísia Trindade Lima as part of a state visit by Spanish president Pedro Sánchez....
Notícias
Data de publicação: 11/03/2024 - 11:15
On March 20th, at 14h, professor Jack A. Tuszynski, from the University of Alberta in Canada and the Polytechnic University of Turin in Italy, will deliver an online research seminar on computational modelling applied to health titled “Measuring and modelling electro conductive and quantum properties of cytoskeletal protein filaments exposed to electromagnetic fields.” The seminar will provide a physics perspective on intracellular...
Notícias
Data de publicação: 06/03/2024 - 09:53
Intending to establish international partnerships for the development and production of technologies, Fiocruz launched the English version of its Innovation Portfolio on Wednesday (2/28). The Innovation Portfolio is Fiocruz's fundamental tool for seeking out national and international partners interested in developing and licensing products that benefit society.
"We can say that the Portfolio is an important tool for strengthening...
Notícias
Data de publicação: 05/03/2024 - 16:07
The Institute of Drug Technology (Farmanguinhos/Fiocruz) announced in 2/28 a partnership agreement with the Brazilian unit of the German pharmaceutical company Boehringer Ingelheim in Rio de Janeiro. This is the first step towards submitting and obtaining registration for a generic product of Jardiance®, empagliflozin 10 mg and 25 mg, with the Brazilian Health Regulatory Agency (Anvisa). The drug is indicated for the treatment of adults with...
Notícias
Data de publicação: 05/03/2024 - 15:43
Living on an extremely low income is a risk factor for a variety of health conditions, such as tuberculosis, malaria and AIDS. Previous studies have shown that public policies such as conditional cash transfer programs are among the most effective interventions for improving the well-being of individuals and families in low- and middle-income countries living in situations of vulnerability. A study published in the scientific journal Nature...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
